Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-21,000
Closed -$1.12M 10719
2014
Q2
$1.12M Buy
21,000
+18,400
+708% +$977K ﹤0.01% 3437
2014
Q1
$136K Sell
2,600
-2,000
-43% -$101K ﹤0.01% 5634
2013
Q4
$247K Sell
4,600
-36,400
-89% -$1.88M ﹤0.01% 5069
2013
Q3
$2.08M Buy
41,000
+39,100
+2,058% +$1.99M ﹤0.01% 2538
2013
Q2
$98K Buy
+1,900
New +$101K ﹤0.01% 5937

Other funds holding SNY

UBS's SNY Position: Q3 2014 in Review

UBS reduced its Sanofi (SNY) stake by 1.7% in Q3 2014, selling an estimated $1.02M and leaving 1,076,236 shares worth $60.7M. The position accounts for 0.04% of the portfolio, ranked #432.

UBS first reported a position in SNY in Q2 2013 and has held it in 6 quarters since. The position peaked at $226M in Q4 2013. 502 funds tracked by Wall St. Rank hold SNY as of Q3 2014.

  • UBS held 1,076,236 shares of Sanofi worth $60.7M as of Q3 2014.
  • UBS sold 19,034 Sanofi shares in Q3 2014, an estimated $1.02M.
  • Sanofi made up 0.04% of UBS's portfolio in Q3 2014, its #432 holding.
  • UBS first reported a position in Sanofi in Q2 2013 and has held it in 6 quarters since.
  • UBS's Sanofi position peaked at $226M in Q4 2013.
  • 502 funds tracked by Wall St. Rank held Sanofi as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.